Equity Method Investment (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Oct. 31, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Gain on deconsolidation of Angel Pharmaceuticals				$ 37,459
Loss from equity method investment		$ 10,005	$ 4,831	234
Net loss		$ (41,307)	(43,241)	(5,995)
Angel Pharmaceuticals
Schedule of Equity Method Investments [Line Items]
Ownership interest (as percent)	53.20%	49.70%
Exclusive grant back period	7 years
Equity reserved (as percent)		7.00%
Investment in Angel, fair value	$ 37,500
Gain on deconsolidation of Angel Pharmaceuticals	$ 37,500
Loss from equity method investment		$ 10,000	4,800	200
Net loss		(11,846)	(5,697)	(274)
Share of loss from investments accounted for using the equity method		$ (10,005)	$ (4,831)	$ (234)